Medicines Discovery
News
Medicines Discovery Catapult achieves ISO 45001 health and safety standard
Medicines Discovery Catapult has been awarded ISO 45001, an international standard for occupational health and safety. The standard is the world’s first international standard for occupational health and safety. Independently certified, it provides a framework to increase safety, reduce workplace risks and enhance health and wellbeing in the workplace.
Compound Semiconductor Applications
News
Compound Semiconductor Applications Catapult wins funding to develop prototype of advanced quantum communication technology
Compound Semiconductor Applications Catapult is part of a consortium that is one of the winners of the Quantum Missions pilot competition, securing a share of £12m of funding from Innovate UK. The collaboration brings together Vector Photonics, Phlux Technology, and the University of Bristol, alongside the Catapult’s expertise. The initiative aims to accelerate the development of quantum computing (QC) and quantum networks (QN) by overcoming barriers to commercialisation – leveraging capabilities already proven by the Catapult’s earlier feasibility study, QUDITS, delivered in 2024.
High Value Manufacturing
News
Future-Proofing UK Food Production: Embracing Innovation to Strengthen Domestic Capabilities
Bhavnita Patel, in the Food and Drink Federation’s “Future Factory” report, highlights how digital innovation, AI, and automation can help UK food producers boost efficiency, address skills gaps, and drive long-term growth. High Value Manufacturing Catapult is supporting businesses to turn these opportunities into reality.
Cell and Gene Therapy
News
Network established to identify opportunities for regulation to support innovation within advanced therapies
A new network will foster collaboration among regulators, industry, and researchers to ensure there is a world-leading regulatory environment in the UK for advanced therapies that supports companies in the development, trial, and launch of these innovative treatments. Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, and the Birmingham Health Partners Centre for Regulatory Science and Innovation (CRSI) established the network with funding from Innovate UK and support from the MHRA.
Energy Systems
News
New Local Area Energy Planning roadmap sets out path for local authorities to attract green investment
Today, Energy Systems Catapult and Phoenix Group launch a new report, ‘Unlocking Regional Investment Through Local Area Energy Planning’, demonstrating that the UK’s transition to Net Zero requires a refreshed approach to financing local energy projects.
Digital
News
Digital Catapult becomes one of the first sites to join national 6G research platform
Digital Catapult, a deep tech innovation organisation, has become one of the first sites to connect to the JOINER (Joint Open Infrastructure for Networks Research) platform, advancing the development and use of data-driven and open future networks in the UK. Led by the University of Bristol’s Smart Internet Lab, the platform is set to accelerate the adoption of future communication and networking technologies, including 6G, nationwide.
Page 1 of 6